Genetic evaluation following MUTYH analysis for European founder variants is critical to identify at-risk patients: A laboratory's experience

The co-occurrence of MUTYH European founder variants and pathogenic variants in separate genes: One laboratory’s experiences and implications for genetic counseling on direct-to-consumer genetic test results

Utilization of a SNP array for homozygosity: Prenatal delineation of recessive diseases

Success of NIPT based on maternal weight and gestational age

Implications of chimerism for cfDNA/NIPT prenatal screening